Following the COVID-19 Experience, Many Patients with Type 1 Diabetes Wish to Use Telemedicine in a Hybrid Format
Open Access
- 28 October 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 18 (21) , 11309
Abstract
Background: The COVID-19 pandemic has brought to light both challenges and unique opportunities regarding type 1 diabetes (T1D) management, including the usage of telemedicine platforms. Methods: This study was conducted in a tertiary hospital diabetes clinic. All consecutive T1D patients during March and June 2021 were asked to fill out a structured anonymous questionnaire that aimed to determine their preference regarding continuous use of a virtual platform. Results: In total, 126 T1D patients answered the questionnaire, of whom 51% were under the age of 40, half were men, half used insulin pumps, and 69% used continuous glucose monitoring. During the pandemic, the exposure of patients to virtual visits has grown about twofold, from 29% to 53%. Of the respondents, 49% expressed an interest in future usage of a virtual platform, but most of them preferred use in a hybrid manner. We found an association between preference to use telemedicine in the future and younger age, previous virtual platform experience, and confidence in being able to download data. Conclusions: Our data demonstrate that the COVID-19 experience has led to a growing interest of T1D patients in using the hybrid format of telemedicine. However, we still need to better understand who will benefit most from this platform and assess its cost-effectiveness and organization.Keywords
This publication has 26 references indexed in Scilit:
- Telemedicine Practice: Review of the Current Ethical and Legal ChallengesTelemedicine and e-Health, 2020
- The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with TelehealthDiabetes Technology & Therapeutics, 2020
- Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and OpportunitiesDiabetes Technology & Therapeutics, 2020
- Telemedicine Consultations and Diabetes Technology During COVID-19Journal of Diabetes Science and Technology, 2020
- Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in ItalyDiabetes Therapy, 2020
- Home Telemedicine (CoYoT1 Clinic): A Novel Approach to Improve Psychosocial Outcomes in Young Adults With DiabetesThe Diabetes Educator, 2019
- Challenges And Opportunities Faced By Large Health Systems Implementing TelehealthHealth Affairs, 2018
- Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trialsCanadian Medical Association Journal, 2016
- Teenagers with poor metabolic control already have a higher risk of microvascular complications as young adultsJournal of Diabetes and its Complications, 2016
- Facilitating Healthy Coping in Patients With DiabetesThe Diabetes Educator, 2012